DBD Strategy Daily - US HEALTHCARE TO OUTPERFORM
US indices are continuing their bull run, unabated. Biotechs have long been lagging behind. They are waking up. We expect Healthcare to outperform in the months to come. Gilead Sciences has passed a couple of resistances since June, it has improved medium term prospects. Amgen is about to...
DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.